1,016
Views
6
CrossRef citations to date
0
Altmetric
Editorial

How far away from having an effective treatment option for progressive multiple sclerosis are we?

ORCID Icon, ORCID Icon & ORCID Icon
Pages 953-955 | Received 18 Mar 2017, Accepted 02 May 2017, Published online: 16 May 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Serena Bonin, Nunzia Zanotta, Arianna Sartori, Alessio Bratina, Paolo Manganotti, Giusto Trevisan & Manola Comar. (2018) Cerebrospinal Fluid Cytokine Expression Profile in Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy. Immunological Investigations 47:2, pages 135-145.
Read now

Articles from other publishers (5)

G. N. Bisaga, M. P. Topuzova, V. A. Malko, D. V. Motorin, Yu. A. Alekseeva, R. Sh. Badaev, T. V. Krinitsina & T. M. Alekseeva. (2023) High-dose chemotherapy with autologous hematopoietic stem cell transplantation in multiple sclerosis: intermediate results of 3 years research. Russian neurological journal 27:6, pages 22-31.
Crossref
Gloria Donninelli, Valeria Studer, Laura Brambilla, Chiara Zecca, Daniele Peluso, Alice Laroni, Daniele Michelis, Renato Mantegazza, Paolo Confalonieri & Elisabetta Volpe. (2021) Immune Soluble Factors in the Cerebrospinal Fluid of Progressive Multiple Sclerosis Patients Segregate Into Two Groups. Frontiers in Immunology 12.
Crossref
Zhile Bai, Duanduan Chen, Luyao Wang, Yu Zhao, Tiantian Liu, Yun Yu, Tianyi Yan & Yong Cheng. (2019) Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients. Frontiers in Neuroscience 13.
Crossref
G. N. Bisaga, A. A. Mikhailenko & I. N. Barsukov. (2019) Progress and prospects of metabolic therapy in multiple sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:3, pages 73.
Crossref
RebeccaM Heidker, MitchellR Emerson & StevenM LeVine. (2017) Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis. Neural Regeneration Research 12:8, pages 1262.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.